Despite challenges, new advances in stem cell biology and genetic engineering show potential for better cell replacement therapies, say experts in a special supplement to JPD Cell replacemen... Read more
FINDING MAY EXPLAIN MANY BRAIN DISORDERS, LEAD TO PREVENTION AND TREATMENT A new study led by Weill Cornell Medical College scientists shows that the most common genetic form of mental retar... Read more
WEILL CORNELL SCIENTISTS REVEAL HOW THE PROTEIN WORKS AND HOW THE DRUG GUMS IT UP, OFFERING NEW HOPE FOR TREATMENT OF AGGRESSIVE CANCER Researchers have discovered how an experimental drug i... Read more
NEW ANTI-COCAINE VACCINE RESEARCH SHOWS DRUG CAN’T REACH THE BRAIN, HUMAN CLINICAL TRIALS ON THE HORIZON Researchers at Weill Cornell Medical College have successfully tested their nov... Read more
Humans don’t “own” their own genes, the cellular chemicals that define who they are and what diseases they might be at risk for. Through more than 40,000 patents on... Read more
“The theory is that if you have a big heart attack, your doctor can just inject these three genes into the scar tissue during surgery and change it back into heart muscle.... Read more
RESEARCHERS FIND LOW COST DRUG WIPES OUT DRUG RESISTANT TB, BUT WORRY IT MAY NOT REACH PATIENTS IN NEED An off-patent anti-inflammatory drug that costs around two cents for a daily dose in d... Read more
Two neuroscientists have created a prosthesis that can partially restore the sight to blind mice. The device could eventually be developed for use in humans. More than 20 million people worl... Read more
Weill Cornell Researchers Develop Novel Anti-Body Vaccine that Blocks Addictive Nicotine Chemicals from Reaching the Brain Researchers at Weill Cornell Medical College have developed and suc... Read more
BIND-014 is the first targeted and programmed nanomedicine to enter human clinical studies A team of scientists, engineers and physicians from Brigham and Women’s Hospital (BWH), Dana-... Read more
The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of a new technology: Cornell Dots, brightly glowing nanoparticles that can light up cancer cells i... Read more
“Cornell Dots” — brightly glowing nanoparticles — may soon be used to light up cancer cells to aid in diagnosing and treating cancer. The U.S. Food and Drug Administr... Read more